Confirmed GSK soft drink sale will refresh buyback coffers
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has agreed to sell its Ribena and Lucozade soft drink brands to Suntory Beverage & Food of Japan. It will receive £1.35bn in cash from Japan's second largest soft drink group, somewhat higher than the £1-1.2bn that had been rumored to be on the cards.